A case of particular-long slow pathway conduction among triple A-V nodal pathway
Li, Q.
Hunan Yi Ke da Xue Xue Bao 23(5): 517; 518
1998
ISSN/ISBN: 1000-5625 PMID: 10682583 Document Number: 491928
Document emailed within 1 workday
Related Documents
Yu, W.C.; Chen, S.A.; Tai, C.T.; Chiang, C.E.; Lee, S.H.; Chiou, C.W.; Ueng, K.C.; Wen, Z.C.; Chen, Y.J.; Huang, J.L.; Feng, A.N.; Chang, M.S. 1997: Radiofrequency catheter ablation of slow pathway in 760 patients with atrioventricular nodal reentrant tachycardia--long-term results Zhonghua Yi Xue Za Zhi 59(2): 71-77Gaita, F.; Haissaguerre, M.; Di Donna, P.; Scaglione, M.; Riccardi, R.; Bocchiardo, M.; Richiardi, E.; Warin, J.F. 1993: Nodal reentry tachycardia: short- and long-term effectiveness and safety of a selective ablation technique of the slow pathway Giornale Italiano di Cardiologia 23(6): 563-574
Mori, A.; Buja, G.F.; Caporicci, D. 1983: Recurrent nodal tachycardia secondary to slow ventricular tachycardia caused by a parasystolic focus localized in an anomalous pathway: description of a case La Clinica Terapeutica 105(1): 61-65
Kohno, T.; Ihara, K.; Sugesawa, K.; Fukada, Y.; Miura, H.; Maesako, N.; Shirota, K.; Yamada, T.; Shiode, N. 2003: Factors of the successful radiofrequency catheter ablation to the slow pathway in patients with uncommon atrioventricular nodal reentrant tachycardia Rinsho Byori. Japanese Journal of Clinical Pathology 51(4): 300-305
Guaragna, R.F.; Lentini, G.; Lombardi, G.; Piazzolla, P.; Bracchetti, D. 1981: Electrophysiologic demonstration of dual atrioventricular nodal pathways and final common pathway in a case of A-V nodal paroxysmal tachycardia. Considerations on the functional complexity of the A-V node Giornale Italiano di Cardiologia 11(4): 517-523
Falkenhein, S.F.; Macdonald, H.; Huber, M.M.; Koch, D.; Parker, C.W. 1980: Effect of the 5-hydroperoxide of eicosatetraenoic acid and inhibitors of the lipoxygenase pathway on the formation of slow reacting substance by rat basophilic leukemia cells; direct evidence that slow reacting substance is a product of the lipoxygenase pathway Journal of Immunology 125(1): 163-168
Ulbricht, L.J.; Emmerich, K.; Wittmann, N.; Probst, H.; Krakau, I.; Horlitz, M.; Klevinghaus, K.; Gülker, H. 1995: Successful high frequency current catheter ablation of an accessory conduction pathway in the "neck region" of a coronary sinus aneurysm. A case report Zeitschrift für Kardiologie 84 Suppl. 2: 137-143
Paparella, N.; Cappato, R.; Alboni, P. 1987: Role of the autonomic nervous system in the genesis of the electrophysiologic pattern of the double nodal pathway Giornale Italiano di Cardiologia 17(11): 941-946
Nakajima, M.; Atsumi, K.; Furuse, A.; Shindo, G.; Kotsuka, H.; Saigusa, M. 1982: Studies on photocoagulation of accessory conduction pathway Kyobu Geka. Japanese Journal of Thoracic Surgery 35(2): 109-115
Motté, G.; Grolleau, R.; Rebuffat, G.; Sebag, C.; Davy, J.M.; Slama, R. 1983: Reciprocating tachycardia and anterograde conduction by a nodoventricular pathway Archives des Maladies du Coeur et des Vaisseaux 76(2): 155-166
Toshima, J.Y.; Toshima, J. 2014: Points of convergence of the endocytic pathway and biosynthetic pathway Seikagaku. Journal of Japanese Biochemical Society 86(6): 788-792
Yasui, K.; Yamazaki, M.; Miyabayashi, M.; Tsuno, T.; Komiyama, A. 1994: Signal transduction pathway in human polymorphonuclear leukocytes for chemotaxis induced by a chemotactic factor. Distinct from the pathway for superoxide anion production Journal of Immunology 152(12): 5922-5929
Kopeć, J.; Edelwejn, Z. 1985: Determination of conduction times of the peripheral and central parts of the sensory pathway using evoked somatosensory potentials Acta Physiologica Polonica 36(3): 216-223
Bagnoli, P.; Brunelli, M.; Magni, F. 1973: Afferent connections to the fast conduction pathway in the central nervous system of the leech Hirudo medicinalis Archives Italiennes de Biologie 111(1): 58-75
Sarubbi, B.; Ducceschi, V.; Esposito, R.; Briglia, N.; Manzo, G.; Mayer, M.S.; Santangelo, L.; Iacono, A. 1996: The pharmacological treatment of supraventricular atrioventricular nodal reentry or accessory pathway reentry tachycardias: the usefulness of transesophageal electrophysiological study in the selection of therapy Cardiologia 41(6): 543-549
Aguado, M.T.; Perrin, L.H.; Ramirez, R.; Miescher, P.A.; Lambert, P.H. 1980: Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins Clinical and Experimental Immunology 42(3): 495-505
Doellgast, G.J.; Triscott, M.X.; Buss, D.H.; West, J. 1988: Extrinsic-pathway enzyme-linked coagulation assay (EP-ELCA). a clot-based alternative to prothrombin time for measurement of extrinsic pathway factors in plasma Clinical Chemistry 34(2): 294-299
Fauchier, J.P.; Rouesnel, P.; Breuillac, J.C.; Cosnay, P.; Scheck, F.; Garnier, L.F. 1994: Injectable and oral cibenzoline in the treatment of supraventricular tachycardia related to intranodal reentry or accessory atrioventricular conduction pathway Annales de Cardiologie et d'Angeiologie 43(4): 194-203
Abdelghaffar, H.; Vazifeh, D.; Labro, M.T. 1997: Erythromycin A-derived macrolides modify the functional activities of human neutrophils by altering the phospholipase D-phosphatidate phosphohydrolase transduction pathway: L-cladinose is involved both in alterations of neutrophil functions and modulation of this transductional pathway Journal of Immunology 159(8): 3995-4005
Wilson, S.F.; Collins, N.P.; Gardiner, B.P. 2000: Clinical pathway for fractured neck of femur: a fractured pathway or crazy paving? Medical Journal of Australia 173(5): 277; Author Reply 278